-
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended Release Tablets USP, 25 mg and 37.5 mg.
25 Sep 2025 22:22 GMT
… its Abbreviated New Drug Application (ANDA) Paroxetine Extended-Release Tablets … of Apotex Inc. Paroxetine Extended-Release Tablets USP, … are indicated for the treatment of Major depressive disorder … .
Shares of Alembic Pharmaceuticals Limited was last trading …
-
Alembic Pharma gets USFDA nod for generic drug to treat depression, anxiety
25 Sep 2025 12:00 GMT
Synopsis
Alembic Pharmaceuticals Ltd. announced it has secured … the USFDA for its generic Paroxetine extended-release tablets, available in …
-
False Alarms: RFK Jr., Antidepressants, and the Real Dangers of Misinformation
24 Sep 2025 17:03 GMT
… part of a pharmaceutical system run amok. … a frontline treatment by medical guidelines in … Doctors and therapists are on the front lines. The FDA … trial of the antidepressant paroxetine (Paxil) in adolescents. The original publication suggested the drug …
-
Physician warns emotional blunting can be a side-effect of antidepressants, shares other risks and withdrawal symptoms
24 Sep 2025 07:35 GMT
… careful tapering under medical supervision. Antidepressants may regulate mood … as part of multimodal treatment plans, but have a … recommends discussing with your doctor to make sure the … drug,” and some studies indicate that escitalopram and paroxetine …
-
7 Medications That May Increase Fall Risk in Older Adults
23 Sep 2025 13:14 GMT
… .”
1. Antidepressants
Examples: Cymbalta (duloxetine), Elavil (amitriptyline), and Paxil (paroxetine)
These medications may impair … may lead a doctor to adjust the dose, switch the drug, or stop …
-
FDA turns down Lundbeck, Otsuka's Rexulti in PTSD on lack of efficacy data
23 Sep 2025 02:33 GMT
… Otsuka Pharmaceutical’s post-traumatic stress disorder (PTSD) hopeful.
The FDA … (sertraline)—as a novel treatment for PTSD, Lundbeck and Otsuka … (SSRIs) Zoloft and Paxil (paroxetine), both of which have had … that one of the trials failed to reach statistical …
-
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
21 Sep 2025 02:15 GMT
… prescribed daily oral medicines for the treatment of schizophrenia. … Adverse Reactions: In trials of elderly patients … of risperidone.
Fluoxetine, paroxetine, and other strong CYP2D6 … WARNING. About Teva
Teva Pharmaceutical Industries Ltd. (NYSE …
-
The Effects of Repetitive Transcranial Magnetic Stimulation on Post-Traumatic Stress Disorder and Parameter Discussion: A Meta-Analysis Based on Randomized Controlled Trials
18 Sep 2025 06:58 GMT
… and methodological differences between trials, heterogeneity in the … a two-week clinical trial design. However, … stimulation combined with paroxetine in treatment of post-traumatic … brain stimulation combined with antidepressant medications for depression: a …
-
No, Antidepressants Do Not Cause School Shootings
16 Sep 2025 19:36 GMT
… British equivalent of the FDA became worried about emotional … 3.5% while on paroxetine (an SSRI no … of paroxetine) shared the details outlined above.
The FDA … starting antidepressant treatment and then “declined progressively after starting medication” ( …
-
No, Antidepressants Do Not Provoke Mass Shootings
12 Sep 2025 17:36 GMT
… shooter’s use of antidepressant medication, particularly the selective … adolescents taking duloxetine, fluoxetine, paroxetine, sertraline, or venlafaxine. … was found” linking medication treatment to the crime.16 … #47;/www.fda.gov/drugs/;fdas-adverse- …
About
© 1995-2025